Mereo BioPharma Group

MREONasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$45.970 M

$0.30 -3.14%

Close of 7 Aug 2026

Revenue

$500.0K

#3556 by revenue

Earnings

$41.9M

#1641 by earnings

Shares outstanding

798,078,829

Latest filing cover page

P/E ratio

1.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#355Impact BiomedicalIBO$46.9M
#356Edesa BiotechEDSA$46.9M
#357Mereo BioPharma GroupMREO$46.0M
#358Context TherapeuticsCNTX$44.5M
#359PDS BiotechnologyPDSB$43.4M

Where these numbers come from

Share counts and financials for Mereo BioPharma Group are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.